α-lactalbumin vaccine
Vaccineexperimental
Clinical trial activity
1 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Oct 1, 2021 (NCT04674306)
Timeline
2020s
- Jan 1, 2021
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Alpha-lactalbuminImmunity, active
LALBA immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04674306 | Early Phase 1 (Phase 1) | Oct 1, 2021 | Case Western Reserve University, Department of Defense, University of Rochester |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Case Western Reserve University | Academic/Hospital | 1 | 1 | 1 | 2021 |
| Department of Defense | Government | 1 | 0 | 1 | 2021 |
| University of Rochester | Academic/Hospital | 1 | 0 | 1 | 2021 |
3 organizations
Page 1 / 1